Lan Shen
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Bladder and Urothelial Cancer Treatments, MicroRNA in disease regulation, Peroxisome Proliferator-Activated Receptors, Tissue Engineering and Regenerative Medicine
Most-Cited Works
- → Cancer-Associated Fibroblast–Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance(2023)142 cited
- → Diastereo- and enantioselective [3 + 3] cycloaddition of spirocyclopropyl oxindoles using both aldonitrones and ketonitrones(2017)105 cited
- → Synthesis and Discovery of Macrocyclic Polyoxygenated Bis-7-azaindolylmaleimides as a Novel Series of Potent and Highly Selective Glycogen Synthase Kinase-3β Inhibitors(2003)82 cited
- → Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3β (GSK-3β) inhibitors(2004)46 cited
- → Synthesis and Identification of [1,2,4]Thiadiazole Derivatives as a New Series of Potent and Orally Active Dual Agonists of Peroxisome Proliferator-Activated Receptors α and δ(2007)45 cited
- → Stereoselective synthesis of the “cyathin” diterpene skeleton via an intramolecular pyrylium ylide-alkene cyclization(1999)42 cited
- → RNA modifications in plant adaptation to abiotic stresses(2024)37 cited
- → Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3β (GSK-3β) inhibitors(2004)35 cited
- → Mono N-arylation of piperazine(III): metal-catalyzed N-arylation and its application to the novel preparations of the antifungal posaconazole and its advanced intermediate(2002)32 cited
- → Synthesis and structure–activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors α/δ dual agonists(2007)27 cited